Abstract.
This article reviews the labelling of peptides that are recognised to be of interest for nuclear medicine or are the subject of ongoing nuclear medicine research. Applications and approaches to the labelling of peptide radiopharmaceuticals are discussed, and drawbacks in their development considered.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blok, D., Feitsma, R., Vermeij, P. et al. Peptide radiopharmaceuticals in nuclear medicine. Eur J Nucl Med 26, 1511–1519 (1999). https://doi.org/10.1007/s002590050488
Issue Date:
DOI: https://doi.org/10.1007/s002590050488